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Abstract 
Astrocytes are morphologically complex and use local translation to regulate distal functions. In order 
to study the distribution of mRNA in astrocytes, we developed a method that combines mRNA 
detection via in situ hybridization with immunostaining of the astrocyte-specific intermediate filament 
glial fibrillary acidic protein (GFAP). mRNAs in GFAP-immunolabelled astrocyte somata, large and 
fine processes were analyzed using AstroDot, a Image J plug-in and the R package AstroStat both 
developed in-house. Taking the characterization of mRNAs encoding GFAP  and  isoforms in the 
hippocampus as a proof of concept, we showed that they mainly colocalized with GFAP processes. 
Gfap  mRNA was more abundant than Gfap  mRNA, and was predominantly found in fine 
processes. In the APPswe/PS1dE9 mouse model of Alzheimer’s disease, Gfap  and Gfap  mRNA 
density and distribution changed as a function of the region of the hippocampus and the astrocyte’s 
proximity to amyloid plaques. In order to validate our new method, we confirmed that the ubiquitous 
Rpl4 (large subunit ribosomal protein 4) mRNA was present in astrocytes processes as well as in 
microglia processes immunolabelled for ionized calcium binding adaptor molecule 1 (Iba1). In 
summary, we have developed a novel, reliable set of tools for characterizing mRNA distribution in 
astrocytes and microglia in physiological or pathological settings. Furthermore, our results suggest that 
intermediate filaments are crucial for distributing mRNA within astrocytes and for modulating specific 
Gfap mRNA profiles in Alzheimer’s disease. 
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Introduction 
Astrocytes are the most abundant glial cells in the brain. Although the astrocytes’ characteristics vary 
from one region of the brain to another, they all have a large number of processes that ramify into 
branches and then secondary branchlets. Hence, protoplasmic astrocytes are large, bushy-shaped cells 
with diameters of ~40-60 μm and volumes of ~104 μm3. Each astrocyte covers a unique domain, and 
(in humans) contacts up to 2 million synapses 
1
. At the synaptic interface, perisynaptic astrocyte 
processes (PAPs) sense the extracellular interstitial fluid, take up neurotransmitters and ions 
2
, and 
release neuroactive factors 
3, 4
. Astrocytes are also in contact with blood vessels; indeed, the latter are 
entirely sheathed in perivascular astrocyte processes (PvAPs) 
5
. The astrocytes at this interface 
modulate the integrity and functions of the blood-brain barrier, immunity 
6
, cerebral blood flow 
7
, and 
interstitial fluid drainage 
8
. The mechanisms underlying the astrocyte’s synaptic and vascular influence 
are critically important, and have attracted much research interest. Indeed, dysregulation of the 
astrocytes’ functions and interplay with neurons and the vascular system contributes to the 
development and progression of most neurological diseases 
7, 9, 10
. 
Recent studies of the astrocyte’s functional polarity have suggested that mRNA distribution and local 
translation regulates protein delivery in space and time. In a previous study, we showed that local 
translation is determined in PvAPs and we characterized the locally translated molecular repertoire 
11
. 
Local translation has also been observed in the radial glia during brain development 
12
 and in PAPs in 
the adult cortex 
13
. Interestingly, these studies showed that some mRNAs were specifically present in 
low or high levels in the astrocyte soma or processes; hence, mRNA distribution appears to obey 
specific rules and meet specific needs, and may help to regulate distal perivascular and perisynaptic 
functions. 
To further characterize the mRNA distribution in astrocytes, we developed a new three-dimensional in 
situ method for identifying astrocyte mRNAs colocalized on GFAP-immunolabelled processes and 
quantifying these levels with dedicated bioinformatics tools. More precisely, we studied the 
distribution of mRNAs encoding the astrocyte-specific GFAP  and  isoforms (generated by 
alternative splicing) in the CA1 and CA3 regions of the hippocampus in wild-type (WT) mice and in 
the APPswe/PS1dE9 mouse model of Alzheimer’s disease (AD). We further showed that our approach 
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can be applied to microglia (immunolabelled for ionized calcium binding adaptor molecule 1 (Iba1)) 
and to all types of mRNA.  
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Results 
 
Gfap  and Gfap  mRNAs are distributed in PAPs 
Gfap mRNAs have already been detected in distal perivascular 
11
 and perisynaptic processes 
13
 of 
astrocytes - suggesting that local GFAP translation regulates distal intermediate filament assembly. 
Although previous research focused on the canonical isoform GFAP , at least 10 GFAP isoforms 
(generated by alterative mRNA splicing and polyadenylation signal selection) have been described 
14-
17
. GFAP  has received special interest because it is a tumour marker 18-20 and is associated with 
neurogenic niches 
21
. In fact, GFAP is encoded by the same first 7 exons as GFAP  but has a 
different C-terminal (Fig. 1A), allowing it to form a heterodimer with GFAP and thus promote 
intermediate filament aggregation 
16, 22
. Here, we first looked for GFAP  and GFAP mRNAs in 
PAPs. Polysomal mRNAs were extracted by translating ribosome affinity purification (TRAP) from 
adult Aldh1-RPL10a mice, which express the ribosomal protein Rpl10a specifically in astrocytes 
23
. 
Extractions were performed either from hippocampus (for whole-astrocyte polysomal mRNAs) or 
synaptogliosome preparations (consisting of apposed pre- and post-synaptic membranes and astrocyte 
PAPs), in order to extract polysomal mRNAs contained in PAPs 
13, 24
. Quantitative qPCR 
amplification of Gfap  and  mRNA was performed using specific primers (Fig. 1B). Both isoforms 
were detected in whole astrocytes (mean ± standard error of the mean level: 8.28±1.99 arbitrary units 
for Gfap  and 1.38±0.20 for Gfap ) and in the perisynaptic processes (17.04±9.09 for Gfap  and 
1.16±0.76 for Gfap ). For polysomal mRNAs, the Gfap α/Gfap  ratio was significantly higher in 
PAPs (40.09±24.27; N=3; p-value=0.05) than in whole astrocytes (5.81±0.67) - suggesting the 
predominance of Gfap in PAPs (Fig. 1B). 
We next sought to visualize Gfap  and mRNAs in hippocampal astrocytes. Fluorescent in situ 
hybridization (FISH) was performed on 30 m thick free-floating adult mouse brain sections, using 
specific fluorophore-coupled RNAscope® probes against Gfap exon 9 and Gfap exon 7a (Fig. 
1C). Next, the astrocytes’ somata and processes were labelled by GFAP immunostaining (Fig. 1C). 
Importantly, the co-immunofluorescent detection of proteins depends on the preservation of their 
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epitopes during the protease digestion step preceding FISH. We observed dense, continuous, GFAP-
labelled arborizations, which indicated that our protocol preserved the GFAP epitopes. In line with the 
qPCR results presented above, Gfap  and mRNA FISH signals were detected as discrete dots in the 
soma and in distal astrocyte areas; Gfap  mRNA (Fig. 1B) was more abundant than Gfap  which 
was mainly present in the somata (Fig. 1C). 
 
AstroDot and AstroStat: bioinformatics tools for analyzing the mRNA distribution in astrocytes 
In order to analyze the distribution of Gfap α and δ mRNAs in astrocytes, we developed AstroDot - a 
dedicated ImageJ plug-in. We had two main objectives: (i) to detect mRNA FISH dots that colocalized 
with GFAP-immunostained astrocyte processes; and (ii) to quantify these dots and analyze their 
distribution in the astrocytes. Confocal images of the CA1 and CA3 regions of the hippocampus were 
acquired and then deconvoluted, so as to eliminate the inherent fluorescence blurring (the point spread 
function (PSF)) and noise, and to increase the resolution (Fig. 2A). For each individual astrocyte, 
regions of interest (ROIs, i.e. the soma and processes) were selected manually by assessing the GFAP 
(intermediate filaments) and DAPI (nuclei) staining and by defining the stack of confocal planes (Fig. 
2B). AstroDot opens with a dialogue box that enables the operator to attribute a specific purpose for 
each of the three fluorescence channels, e.g. “DAPI” for nuclear staining, “IF” for GFAP 
immunofluorescence, and “Dots” for FISH dot thresholding and detection (Fig. 2C). This dialogue box 
also contains a “Specific mRNA” option, which can be selected when the mRNAs are expressed only 
in the cell type of interest. In such a case, all mRNA FISH dots are considered to belong to this cell 
type. The first step in the analysis was calculation of the mean GFAP immunofluorescence 
background, i.e. the value above which the signal was considered to be positive. In the second step, 
each astrocyte nucleus was defined; given that astrocytes interact with other brain cell types, some 
ROIs can contain more than one nucleus. AstroDot was designed to optimize the recognition of 
astrocyte nuclei on the basis on the GFAP immunostaining. The putative astrocyte nucleus appears in 
green, and any other nuclei appears in red. A dialogue box allows the operator to confirm or modify 
AstroDot’s automatic selection by clicking on the correct nucleus (Fig. 2D). AstroDot then starts to 
detect astrocyte mRNAs, based on their specific colocalization with GFAP. A distance map was used 
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to calculate the diameter of each GFAP-immunolabelled process. Processes with a diameter greater 
than the minimum distance between two confocal planes (0.3 m, in the present case), were defined as 
“large”, and those with a smaller diameter were defined as “fine” (Fig. 2E). The somatic domain of 
each astrocyte corresponded to the DAPI staining and the surrounding 2 m space. A TIF image was 
generated for each ROI (Fig. 2F). The mRNA FISH dots appeared in red if they were outside 
astrocytes, in green if they colocalized with astrocyte large processes and somata, or in yellow if they 
colocalized with astrocyte fine processes (Fig. 2F). All the results were automatically entered on a 
table with the following items for each ROI: Image name; ROI name; Background intensity; Astrocyte 
volume; Dot density in astrocytes; Percentage of dots not in astrocytes; Percentage of dots in astrocyte 
somata; Percentage of dots in astrocyte fine processes; Percentage of dots in astrocyte large processes; 
Mean astrocyte process diameter. To facilitate the statistical analysis of AstroDot data, we developed 
an optional R package named AstroStat; it automatically calculates and compares the mean ± standard 
deviation values, and produces a summary report on the results. 
 
Characterization of Gfap  and mRNAs in CA1 and CA3 hippocampal astrocytes from WT 
mice and the APPswe/PS1dE9 mouse model of AD. 
We analyzed the density and distribution of Gfap  and Gfap  mRNAs in CA1 and CA3 hippocampal 
adult astrocytes in WT adult mice by using AstroDot’s “Specific mRNA” option (Fig. 3 and Table 
S2). Comparison of the astrocytes in CA1 vs. CA3 indicated that CA1 astrocytes had a slightly greater 
overall volume but displayed processes with the same mean diameter (Fig. 3A). The Gfap /Gfap  
mRNA ratio was the same in the two regions (Fig. 3B). Overall, and in line with our initial qPCR 
analysis (Fig. 1B), Gfap  was 5.2 times more abundant than Gfap  in both CA1 and CA3 (Fig. 3C). 
Both mRNAs were more abundant in the processes (Gfap ± 6.7 SD in CA1 and 86.7 ± 8.1 
SD in CA3 Gfap ± 11.3 SD in CA1 and 71.5 ± 16.4 SD in CA3 than in the soma. Gfap  
was more abundant than Gfap in the soma and in large processes Fig. 3D). We analyzed the data 
without taking account of the astrocytic-specific nature of GFAP expression (Fig. 3E). In this case, 
both Gfap  and Gfap  mRNAs were colocalized on GFAP-labelled intermediate filaments in CA1 
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(mean ± SD: 59.5 ± 9.0 for Gfap  and 74.4 ± 11.0) and CA3 (62.2 ± 10.1 for Gfap  and 74.7 ± 12.4 
for Gfap ) - suggesting that the majority of Gfap RNAs are associated with intermediate filaments 
(Fig. 3E). 
Astrocytes are involved in neuroinflammation, and become reactive in virtually all pathological 
situations in the brain. Astrocyte reactivity is characterized by GFAP overexpression and subsequent 
morphological changes, such as process hypertrophy and remodelling 
17
. Hence, we next sought to 
study Gfap  and mRNAs in reactive astrocytes. We choose the example of AD, in which astrocytes 
undergo drastic morphological and molecular changes that perturb their physiology 
25, 26
. Using the 
method described above, Gfap  and  mRNA FISH dots were detected on GFAP-immunolabelled 
sections of CA1 and CA3 hippocampus from 9-month-old APPswe/PS1dE9 mice (Fig. 4). We 
quantified astrocytes associated with a beta-amyloid plaque (A, labelled with DAPI) or more than 30 
μm from an A plaque (Fig. 5 and Table S2). As reported in the literature, CA1 and CA3 astrocytes 
from APP/PS1dE9 mice were larger than those from WT mice (Fig. 5A) but had a slightly smaller 
process diameter (Fig. 5A). In astrocytes not associated with A, the Gfap  ratio was slightly but 
significantly higher (by a factor of 1.3) in CA1 and CA3 (Fig. 5B), with a higher Gfap mRNA level 
in fine processes only (Fig. 4A, 5F). In contrast, the Gfap  mRNA density was the same as in WT 
mice in CA1 and CA3 (Fig. 5C). However, the distribution of this mRNA within the astrocytes 
differed; levels in large processes were lower (relative to the WT) in CA1 and CA3 (Fig. 5E), and 
levels in fine processes were higher in CA3 only (Fig. 5F). The relative differences in mRNA levels 
were greater in A-associated astrocytes (Fig. 4B); the density of Gfap  mRNAs was significantly 
higher than in WT cells (5.0-fold for CA1, and 4.7-fold in CA3) or in astrocytes not associated with 
A (3.8-fold for CA1, and 3.7-fold in CA3) (Fig. 5C). The distribution of Gfap  mRNA also differed, 
with lower levels (relative to the WT) in the soma (Fig. 5D) and in large processes (only in CA1) (Fig. 
5E) and higher levels in fine processes in CA1 and CA3 (Fig. 5F). The same effect was observed for 
the Gfap mRNA, with a greater abundance in A-associated astrocytes than in WT samples (3.6-fold 
for CA1, and 3.5-fold in CA3) or in astrocytes far from plaques (3.3-fold for CA1, and 3.4-fold in 
CA3) (Fig. 5C). The redistribution was most prominent in fine processes in CA1 and CA3 (Fig. 5F). 
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These results show that the density and distribution of Gfap  and Gfap  mRNAs vary markedly as a 
function of the astrocyte’s reactivity status, the brain area, and the proximity of A deposits. 
 
Application of AstroDot and AstroStat to the analysis of ubiquitous mRNAs in astrocytes and 
microglia 
To further validate our approach, we studied the distribution of Rpl4 mRNA (a ubiquitously expressed 
mRNA encoding the large subunit ribosomal protein 4) in CA1 (Fig. 6A). Interestingly, 62.52% ± 
11.77 of the Rpl4 mRNA FISH dots were localized in astrocytes (n=67). Of these, 83.33% ± 5.41 were 
present in fine GFAP-immunolabelled processes, with 9.59% ± 3.45 in large GFAP-immunolabelled 
processes, and 7.09% ± 4.14 in somata. This result was unexpected because Rpl4 integrates into the 
60S ribosome subunit in the nucleus 
27
 but was corroborated by a qPCR analysis (performed as 
described above) of polysomal mRNAs extracted by TRAP from adult Aldh1L1-RPL10a mouse 
hippocampus or PAPs; in the latter, Rpl4 was enriched 120-fold (p=0.05, n=3) (Fig. 6B). To study the 
distribution of non-astrocyte Rpl4 mRNA FISH dots, we performed an additional, independent 
experiment by immunostaining the specific microglial marker Iba1. As with the GFAP 
immunofluorescence experiments, our FISH protocol was designed to protect Iba1’s epitopes; the 
protein was detected throughout the somata and processes (Fig. 6C). Our analysis of the distribution of 
Rpl4 mRNA in microglia (n=28) indicated that 16.07% ± 4.47 of the Rpl4 mRNA FISH dots were 
localized in microglial processes. Of these, 37.72% ± 9.24 were localized in fine processes, with 
27.06% ± 10.78 in large processes and 35.22% ± 10.13 in somata. 
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Discussion 
 
Although local translation has been recently described in astrocyte processes, tools for studying the 
distribution of astrocyte mRNAs were not previously available. Accordingly, we developed a co-
labelling method that combined mRNA in situ hybridization, the immunofluorescence detection of 
GFAP-containing intermediate filaments on brain slices, confocal imaging, and a bioinformatics 
analysis of mRNA density and distribution in astrocytes. 
A key technical obstacle to the implementation of this approach was the risk of protein epitope 
degradation during the protease digestion step that precedes in situ RNA hybridization. Our previous 
tests on transgenic hGfap-eGFP mouse brain sections (in which eGFP fills the astrocyte cytoplasm) 
28
 
indicated that these adaptations were not sufficient to preserve eGFP (data not shown), and thus 
precluded the use of this reporter mouse strain to detect astrocytes in parallel with in situ 
hybridization. In contrast to previous reports
11, 12
, however, our protocol preserved GFAP and enabled 
us to perform parallel in situ hybridization and GFAP immunodetection. Interestingly, these conditions 
also allowed us to immunodetect the microglia-specific protein Iba1. It is noteworthy that GFAP is not 
expressed uniformly in the brain, and so GFAP immunolabelling is somewhat limited by its lack of 
applicability to all brain regions. Nevertheless, our optimization of the GFAP immunolabeling makes 
it possible to distinguish between strongly labelled astrocyte processes and their secondary extensions 
in regions where GFAP is highly expressed (e.g. the hippocampus, olfactory bulbs, cerebellum, and 
hypothalamus). Another advantage of immunolabelling GFAP and Iba1 relates to the fact that both 
proteins are standard markers of glial reactivity - a process initiated in response to immune attack, 
chronic neurodegenerative disease, or acute trauma 
29
 . Hence, GFAP and Iba1 immunolabelling could 
therefore be used to address possible changes in mRNA distribution in reactive astrocytes and 
microglia, as demonstrated here in APPswe/PS1dE9 mice.  
It was previously determined that GFAP immunolabeling delineates only 15% of the total astrocyte 
volume 
30
. Nevertheless, we found that the majority of the Gfap  and  mRNA dots were attributed to 
GFAP processes. The mRNA dots not detected in GFAP intermediate filaments probably belonged to 
fine distal astrocyte processes devoid of GFAP (e.g. PAPs). These observations suggest that the 
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majority of Gfap mRNAs are bound to intermediate filaments, and are consistent with previous reports 
of colocalization between mRNAs encoding collagens 
31
 and alkaline phosphatase 
32
 on one hand and 
vimentin (another intermediate filament protein) on the other. Taken as a whole, these findings suggest 
that intermediate filaments may have crucial roles in the distal distribution of mRNAs. Consequently, 
it is conceivable that GFAP alterations, deficiency or upregulation (one or the other of which occurs in 
most neuropathological conditions
17
) might greatly modified the distribution of astrocyte mRNAs and 
their local translation. In turn, these changes might alter the astrocytes’ functions - particularly at their 
synaptic and vascular interfaces. 
In order to demonstrate the applicability of our approach, we first focused on mRNAs encoding (i) the 
canonical  isoform of GFAP and (ii) the  Cter variant, the assembly of which with GFAP 
promotes intermediate filament aggregation and dynamic changes 16, 22. Interestingly, the results of 
our experiments in WT mice showed that Gfap  mRNA was more likely than Gfap  mRNA to be 
found in the astrocyte soma. This finding corroborated the results of a previous in vitro study in which 
the proportion of mRNA in primary astrocyte protrusions was higher for Gfap  than for Gfap  33. 
The high Gfap and mRNA density observed in plaque-associated astrocytes was also consistent 
with previous qPCR-based assays of mRNA in the cortex of APPswe/PS1dE9 mice 
15
. Interestingly, 
levels of human GFAP and isoforms are elevated in plaque-associated astrocytes in the CA 1-3 
region 
34
. Taken together, these results and our observations of elevated mRNA density and 
distribution in the fine processes of plaque-associated astrocytes suggest that local translation of Gfap 
and mRNA might be a critical mechanism for regulating intermediate filament dynamics in distal 
astrocyte processes during the progression of AD. Given that the GFAP  isoform ratio is known to 
strongly influence astrocyte proliferation and malignancy 
35, 36
, our approach might constitute a 
valuable tool for accurately assessing the differentiation state of astrocytomas in preclinical and 
clinical settings. 
Lastly, we demonstrated that our approach is applicable to any type of mRNA and can also be used in 
microglia. In fact, the present study is the first to have demonstrated that mRNAs are distributed 
across microglial processes; this is an important observation in view of the microglia’s complex 
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morphology, motility, and roles in immune surveillance and synaptic remodelling in the brain 
37
. Our 
results strongly suggest that mRNA distribution and local translation are of physiological significance 
in this important neural cell type. In conclusion, our new semi-automated in situ histological method is 
the first to have characterized mRNA distribution in astrocytes and microglia. 
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Materials and Methods 
 
Mice 
Aldh1L1-Rpl10a mice 
23
 and C57BL6 WT mice were born and then housed under pathogen-free 
conditions in the animal facility at the Centre Interdisciplinaire de Recherche en Biologie (CIRB, 
Collège de France, Paris, France). The APPswe/PS1dE9 
38
 mice were born and housed in the MIRCen 
animal facility (CEA, Fontenay-aux-Roses, France). 
Ethical approval 
All experiments were approved by the French Ministry of Research and Higher Education, and 
conducted in accordance with the host institution’s ethical standards (Collège de France, Paris, 
France).  
 
Aldh1L1:l10a-eGFP TRAP from whole astrocytes and PAPs, and qPCR 
Two hippocampi from 5-month-old mice were used for whole-astrocyte polysome extraction. 
Synaptosomes were prepared from four hippocampi, as described in 
24
 for perisynaptic astrocyte 
extraction. Polysomes were extracted using the method described in 
39
. Three independent samples 
were prepared for qPCR analysis. Messenger RNAs were purified using the RNeasy Lipid tissue kit 
(Qiagen). cDNA was synthesized from 100 ng of whole-astrocyte RNA or the all the PAP mRNA 
using a Reverse Transcriptase Superscript III kit (Invitrogen) with random primers, and stored at -
20°C. Next, 1 μL of cDNA suspension was pre-amplified using SoAmp reagent (BioRad), and droplet 
qPCR was performed using a QX200™ Droplet Digital™ PCR System (BioRad). The cDNA content 
was normalized against 45S RNA. TaqMan probes and primer references are listed in Table S1. The 
data were analyzed by applying a one-way unpaired Mann-Whitney test. The threshold for statistical 
significance was set to p<0.05. 
 
Brain slice preparation 
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Nine-month-old mice were anesthetized with a mix of ketamine/xylazine (0.1 mL/mg) and killed by 
transcardiac perfusion with 1X phosphate-buffered saline (PBS)/4% paraformaldehyde (PFA) The 
brain was removed and immersed in 4% PFA overnight at 4°C. The PFA solution was replaced with 
15% sucrose for 24 h at 4°C and, lastly, by 30% sucrose for 24 h at 4°C. The brains were cut into 30 
µm-thick coronal sections using a Leitz microtome (1400). Sections were stored at -20°C in a 
cryoprotectant solution (30% glycerol and 30% ethylene glycol in 1X PBS). 
 
Fluorescent in situ hybridization and immunostaining 
Slice preparation: Slices were carefully washed three times with 1X PBS in a 24-well plate. For the 
last wash, the 1X PBS was replaced with 7 drops of RNAscope® hydrogen peroxide solution 
(Advanced Cell Diagnostics Inc.) for 10 min at room temperature (RT); this blocked endogenous 
peroxidase activity, and resulted in the formation of small bubbles. The slices were washed in Tris-
buffered saline with Tween® (50 mM Tris-Cl, pH 7.6; 150 mM NaCl, 0.1% Tween® 20) at RT, and 
mounted on Super Frost+®-treated glass slides using a paintbrush. Slices were dried at RT for 1 hour 
in the dark, quickly (in less than 3 s) immersed in deionized water in a glass chamber, dried again for 1 
hour at RT in the dark, incubated for 1 h at 60°C in a dry oven, and dried again at RT overnight in the 
dark. 
The slices were rehydrated by rapid immersion (for less than 3 s) in deionized water at RT. Excess 
liquid was removed with an absorbent paper, and a hydrophobic barrier was drawn. A drop of pure 
ethanol was applied on the slice for less than 3 s and removed using an absorbing paper. The slides 
were incubated at 100°C in a steamer, while ensuring that condensation did not fall back on them. A 
drop of preheated RNAscope® 1X Target Retrieval Reagent (Advanced Cell Diagnostics Inc.) was 
added to the steamer, and the slides were left for 15 minutes. Next, the slides were washed three times 
in deionized water at RT, and excess liquid was removed with absorbent paper. A drop of 100% 
ethanol was applied for 3 minutes, and excess liquid was then removed. A drop of RNAscope® 
Protease+ solution (Advanced Cell Diagnostics Inc.) was applied and slices were incubated at 40°C in 
a humid box for 30 minutes. Target retrieval treatment and RNAscope® Protease+ treatment were 
used to unmask the mRNAs. Lastly, the slides were washed three times with deionized water at RT. 
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FISH and immunostaining: FISH was performed using the RNAscope® Multiplex Fluorescent 
Reagent Kit v2 (Advanced Cell Diagnostics Inc.) and specific probes (Table S1), according to the 
manufacturer’s instructions. Following the FISH procedure, slides were incubated with a blocking 
solution (5% normal goat serum, 0.375% Triton X-100, and 1 mg.mL
-1
 bovine serum albumin in 1X 
PBS) for 1 hour at RT, incubated with the primary antibody overnight at 4°C (Table S1), rinsed three 
times with 1X PBS, and incubated with the secondary antibody (Table S1) for 2h at RT. Lastly, the 
slides were washed three times in 1X PBS and mounted in Fluor mount and DAPI (Southern Biotech). 
 
Imaging 
Images were acquired using a Yokogawa W1 Spinning Disk confocal microscope (Zeiss) with a 63x 
oil objective (1.4 numerical aperture). The imaging conditions and acquisition parameters were the 
same for all slides. The experimental PSF was obtained using carboxylate microsphere beads 
(diameter: 170 nm; Invitrogen/ThermoFisher Corp.). Except for DAPI, all channels were deconvoluted 
with Huygens Essential software (version 19.04, Scientific Volume Imaging, The Netherlands; 
http://svi.nl), using the classic maximum likelihood estimation algorithm and a signal-to-noise ratio of 
50 (for the immunofluorescence channel) or 20 (for the FISH channel), a quality change threshold of 
0.01, and 150 iterations at most. 
 
AstroDot and AstroStat 
As shown in the Results section, AstroDot can be used to study mRNA density and distribution not 
only in astrocytes but also in microglia immunolabelled for Iba1. In addition to FISH signals, 
AstroDot can be used to quantify any type of dot-shaped fluorescence signal. AstroStat was used to 
analyze the AstroDot results table, using an R script. The programs can be downloaded free of charge 
from https://github.com/pmailly/Astrocyte_RNA_Analyze and https://github.com/rtortuyaux/astroStat, 
respectively. 
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For AstroDot, an image analysis plug-in was developed for the ImageJ/Fiji software 
40, 41
, using Bio-
Format (openmicroscopy.org), mcib3D 
42
, GDSC (A. Herbert, https://github.com) and local thickness 
(B. Dougherty, https://imagej.net/Local_Thickness) libraries.  
An ROI enclosing each astrocyte was drawn by hand, using the Fiji polygon tool on the Z projection 
of the stack. In the ROI Manager, the ROI names were coded as (roi_number-z_top-z_bottom) and 
saved in a zip file. 
Plug-in features: The plug-in was designed to process all images in a specific folder containing 
MetaMorph .nd files, and to read metadata images (channel name, z step, etc.), deconvoluted image 
channels (except for DAPI), and ROI zip files. 
AstroDot processing: 
1) AstroDot’s parameters (the image folder, the channel order, the threshold method, etc.) were 
displayed in a dialogue box (see Fig. 2C). 
2) The immunofluorescence background was estimated using a 0.5 median filter, a binary mask 
(using Li’s threshold method), and an inversion of the binary mask43, 44.The immunofluorescence 
value was multiplied by the inverted mask and then divided by 255. The background value 
(bgThreshold) was defined as the mean intensity of all voxels other than those with a value of 
zero. 
3) For each ROI, a substack corresponding to zTop and zBottom (defined in the ROI name) was 
created for all channels. 
4) Semi-automatic determination of the astrocyte or microglial cell nucleus: DAPI fluorescence was 
processed using a difference of Gaussian filter (kernel: 28–30), a binary mask (using Otsu’s 
threshold method) and a three-dimensional watershed, to separate nucleus clusters 
45
. An astrocyte 
nucleus was selected on the basis of its high GFAP immunofluorescence intensity, and was 
displayed in green. All other detected nuclei were displayed in red. A dialogue box enabled the 
user to confirm or correct the software’s choice of nuclei. 
5) The GFAP immunofluorescence was processed using a 0.5 median filter and a binary mask, using 
Li’s threshold method. The three-dimensional local thickness of the processes was used to 
generate a distance map and calculate the local process diameters. 
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6) FISH dot channel processing: a value of 500 (a manual estimation of the background after 
deconvolution) was subtracted from each voxel. A difference of Gaussian filter (kernel: 3–1) and a 
binary mask were applied, using the threshold method defined in the “parameters” dialogue box. 
The mean dot size volume was computed after the exclusion of dot clusters (volume >2 µm
3
). For 
dot clusters (which arise when mRNAs are strongly expressed), the dot number was calculated by 
dividing the cluster by the previously determined mean dot size volume. For each dot, the mean 
intensity in the Gfap immunofluorescence channel and the distance map value (the process 
diameter) was calculated. 
7) FISH dot classification into three categories: 
a) Dot 0 (in red) was a dot in the immunofluorescence background (without using the “Specific 
mRNA” option only): mean GFAP immunofluorescence intensity ≤ bgThreshold; distance to 
the boundary of the nucleus > 2 µm. 
b) Dot 1 (in yellow) was a dot in a fine process: mean GFAP immunofluorescence intensity 
>bgThreshold; distance to the boundary of the nucleus >2 µm; astrocyte process diameter < 
step in the z calibration (0.3 µm). 
c) Dot 2 (green) was a dot in a large process: mean GFAP immunofluorescence intensity 
>bgThreshold; distance to the boundary of the nucleus >2 µm; astrocyte process diameter > 
step in the z calibration (0.3 µm); or a dot in the soma if the distance to the boundary of the 
nucleus 2 µm. 
Hence, Dots 1 and 2 were inside astrocytes, and Dots 0 were outside astrocytes. 
8) For each image and for each computed ROI, a .csv output table was generated with the 
following headers: Image name; ROI name; Background intensity; Astrocyte volume; Dot density 
inside astrocytes (number of dots 1 + number of dots 2) / astrocyte volume); Percentage of dots 
outside the astrocyte (number of dots 0 / total dot number); Percentage of dots in astrocyte somata  
(number of dots less than 2 µm from the boundary of the nucleus / number of dots in astrocytes); 
Percentage of dots in fine processes (number of dots 1 / number of dots in astrocytes); Percentage 
of dots in large processes (number of dots 2 – number of dots in somata) / number of astrocyte 
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dots); Mean astrocyte diameter. For each image and each ROI, the selected nucleus, astrocyte 
channel and classified dot populations were saved as .TIF images. 
 
AstroStat was designed to (i) define the template analysis using a checkbox (working directory, 
conditions to be compared, paired or unpaired analysis, or data normality plot); (ii) pool data 
appropriately for each mouse; (iii) test the normality of the data distribution of each group (using 
Shapiro’s test). If there were more than 30 cells in each group, the central limit theorem was applied; 
(iv) test the equality of variance (using Fisher’s test) for an unpaired analysis; and (v) compare the 
means using: 
an unpaired analysis: 
 a) Student’s t-test, for normally distributed data and equal variances 
 b) Welch-Satterthwaite’s test, for a normal data distribution and unequal variances 
 c) Wilcoxon’s test for non-normally distributed data 
or a paired analysis: 
 a) Paired Student’s t test for normally distributed data  
 b) Wilcoxon signed rank test for non-normally distributed data 
The threshold for statistical significance was set to p<0.05. 
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Figure legends 
 
Fig. 1: Detection of Gfap  and  mRNAs in hippocampal astrocytes. A. Schematic representation 
of mouse GFAP  and GFAP  isoforms. The positions of the qPCR and FISH probes are indicated by 
an asterisk. B. Polysomal Gfap α and  RNA levels in hippocampal astrocytes and perisynaptic 
astrocyte processes (PAPs), determined by qPCR and normalized against 45S RNA. Statistical 
significance was determined in a one-way unpaired Mann-Whitney test; *, p<0.05; ns: not significant. 
C. Merged and separated images of a deconvoluted confocal z-stack of a CA1 astrocyte, with FISH 
detection of Gfap α (in green) and Gfap  (in red) mRNAs and co-immunofluorescent detection (IF) of 
GFAP (in grey). The nucleus was stained with DAPI (in blue). Note the abundance of Gfap α mRNA 
FISH dots (relative to Gfap in distal areas of the astrocyteScale bar, 10m. 
 
Fig. 2: AstroDot image processing. All images correspond to a single confocal z-stack for a CA1 
astrocyte. A. Effect of deconvolution on GFAP immunofluorescence: left panel: the raw confocal 
image; right panel: the deconvoluted image. B. Selection of ROIs (yellow circles). C. AstroDot 
dialogue box for the definition of fluorescence channels, the threshold method for FISH dots, and the 
choice of the “Specific mRNA” option. D. Detection of the astrocyte nucleus (in green) and other 
nuclei (in red). E. A heat map of GFAP immunofluorescence, used to calculate the process diameter. F 
AstroDot’s interpretation of the results for Gfap α and Gfap mRNAs, with the “Specific mRNA” 
option active. Green dots are located in the soma or large GFAP-labelled processes. Yellow dots are 
located in fine processes. Scale bar: 10m. 
 
Fig. 3: The distribution of Gfap and mRNAs in CA1 and CA3 hippocampal astrocytes. 
A. Astrocyte volume, and process diameter. B. The Gfap /Gfap  mRNA ratio. C. Total mRNA 
density: number of RNA FISH dots/m x 100. D. Percentages of Gfap  and mRNAs in astrocyte 
somata, fine processes and large processes. E. Percentages Gfap  and mRNA dots colocalized with 
GFAP when the “Specific mRNA” option was not applied. In total, 175 CA1 and 94 CA3 astrocytes 
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were analyzed. Statistical significance was determined in two-way unpaired Student’s t-tests. *, 
p<0.05; ****, p<0.0001; ns: not significant. 
 
Fig. 4: Detection of Gfap  and mRNAs in CA1 hippocampal APPswe/PS1dE9 astrocytes. A. 
Merged and separated images of a deconvoluted confocal z-stack of APPswe/PS1dE9 CA1 astrocytes, 
with FISH detection of Gfap α mRNA (in green) and Gfap  mRNA (in red) and co-
immunofluorescent detection of GFAP (in grey). The nucleus and an amyloid deposit (circled by a 
dotted line, and indicated by “P”) are stained with DAPI (in blue). The ROI #1 (yellow circle) is an 
astrocyte close to an A deposit. The ROI #2 is located more than 60 m from an Adeposit. B. TIF 
images of ROIs #1 and #2 for Gfap α and  mRNA, as analyzed with AstroDot using the “Specific 
mRNA” option. Green dots belong to the soma and large GFAP-labelled immunofluorescent 
processes. Yellow dots belong to fine processes. Scale bar: 20m. 
 
Fig. 5: Comparison of Gfap and mRNA densities and distributions in CA1 and CA3 
hippocampal astrocytes from WT and APPswe/PS1dE9 mice. A. Astrocyte volume and process 
diameter. B. The Gfap /Gfap  mRNA ratio. C. mRNA density: number of RNA FISH dots/m x 
100. D. Percentages of Gfap  and mRNA dots in astrocyte somata, fine processes, and large 
processes. E. Percentages of Gfap  and mRNA dots colocalized with GFAP. Analyses were 
performed on 175 CA1 WT astrocytes, 94 CA3 WT astrocytes, 127 APPswe/PS1dE9 CA1 astrocytes 
not associated with plaques, 78 APPswe/PS1dE9 CA3 astrocytes not associated with plaques, 27 
plaque-associated CA1 APPswe/PS1dE9 astrocytes, and 28 plaque-associated CA3 APPswe/PS1dE9 
astrocytes. Statistical significance was determined using two-way unpaired Student’s t-tests. * p<0.05; 
** p<0.001; *** p<0.001: **** p<0.0001; ns: not significant. 
 
Fig. 6: Detection and characterization of Rpl4 mRNA distribution in CA1 hippocampal 
astrocytes and microglia. A. Left: Confocal z-stack of a CA1 astrocyte with FISH detection of Rpl4 
mRNA (in red) and co-immunofluorescent GFAP detection (in grey). The nucleus is stained with 
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DAPI (in blue). Right: AstroDot analysis: Green dots are located in the soma or in GFAP-
immunolabelled large processes; yellow dots are located in GFAP-immunolabelled fine processes; red 
dots are not colocalized with GFAP (i.e. excluded RNAs). B. The polysomal Rpl4 RNA level in 
hippocampal astrocytes and PAPs, determined by qPCR and normalized against 45S RNA. Statistical 
significance was determined in a one-way unpaired Mann Whitney’s test; *, p<0.05. C. Left: Confocal 
z-stack of a CA1 microglial cell with FISH detection of Rpl4 mRNA (in red) and co-
immunofluorescent Iba1 (in grey). The nucleus was stained with DAPI (in blue). Right: the AstroDot 
analysis: Green dots are located in the soma or Iba1-immunolabelled large processes; yellow dots are 
located in Iba1-immunolabelled fine processes; red dots did not colocalize with Iba1 (i.e. excluded 
RNAs). Scale bar; 10m. 
 
Supplementary Table S1. Antibodies, qPCR and FISH probes and reagents 
 
Supplementary Table S2. Raw data (analyzed using AstroDot and AstroStat) for Gfap α and 
Gfap  mRNAs in CA1 and CA3 hippocampal astrocytes from WT and APPswe/PS1dE9 mice. 
SD, standard deviation; N, number of cells analyzed.  
 
 
 
 
 
 
